Comparing treatments for early missed abortion
Official title: A Real-World Study Comparing the Efficacy of Different Treatment Regimens for Early Missed Abortion
Run by The Third Xiangya Hospital of Central South University · NCT07422506 · Data updated 2026-11-12
This project will see if different treatment methods and estrogen doses help people with early missed abortion recover safely and reduce complications.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 40 Years |
| Sex | Women only |
| Enrollment | 580 (estimated) |
| Sponsor | The Third Xiangya Hospital of Central South University Academic / other |
| Locations | 1 site (Changsha, Hunan) |
| Status | Recruiting |
| Started | January 1, 2024 |
| Main results expected | January 1, 2030 |
| Study ends | January 1, 2035 |
| Registry record updated | February 20, 2026 |
| Trial ID | NCT07422506 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
People aged 18–40 with imaging- and lab-confirmed early missed abortion, normal routine exam results, no need for emergency curettage, and the ability to attend follow-up are the intended participants.
✕Probably not a fit
Patients with contraindications to medical abortion or estrogen, heavy vaginal bleeding, thromboembolic disease, hormone-dependent tumors, severe organ disease, or inability to follow up are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This research collects clinical data to compare surgical versus medical management for early missed abortion and tracks reproductive outcomes. It has two parts: a retrospective analysis comparing past cases of surgery and drug treatment, and a prospective phase testing different estrogen doses combined with either surgery or medical induction. Investigators will compare treatment success rates, complication rates, and subsequent fertility outcomes using statistical analyses. The aim is to find regimens that achieve complete uterine evacuation with fewer complications and clearer guidance on estrogen dosing.
Why it matters
Potential benefit: If successful, the results could identify treatment approaches that lower complication rates and improve reproductive outcomes after early missed abortion.
How similar studies have gone: Previous research has compared surgical and medical management for missed abortion, but using high-dose estrogen as an adjunct is less well studied and evidence is limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * ①Age 18-40 years old; ②Early pregnancy missed abortion confirmed by imaging and laboratory tests; ③All indicators of routine examinations before treatment are within the normal range, and there are no serious systemic diseases; ④No indications for emergency curettage; ⑤Good compliance, follow-up observation as required (prospective study). Exclusion Criteria: * ①Contraindications to medical abortion; ②Those who are allergic to estrogen and have contraindications to the use of estrogen; ③Those who cannot be followed up according to the follow-up plan; ④Thromboembolic diseases, known or suspected history of breast cancer, hormone-dependent tumors, etc.; ⑤Vaginal bleeding exceeds the usual menstrual volume; ⑥Those with severe heart, liver and kidney diseases; ⑦Accompanied by serious internal and surgical diseases, malignant tumors or mental illnesses, and cannot cooperate.
Where it's running
-
The Third Xiangya Hospital of Central South University
Changsha, Hunan, China Recruiting
Study contacts
- Study coordinator: Dabao Xu
- Email: forxudabao@126.com
- Phone: 13017386201
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Periodontal Infection and Inflammatory Markers in Missed Abortion
Researchers will test whether gum infection and inflammation are linked to missed abortion in pregnant women with no major chromosomal problems.
-
Remote follow-up with a connected app after emergency gynecological care
This trial tests if using a secure connected health app for remote follow-up improves satisfaction and clinical outcomes for women aged 18–60 after emergency gynecological visits.
-
EARLY-PREG: Mapping maternal–embryo molecular communication before and after conception
This project will test whether patterns of proteins and other molecules in maternal fluids change in the first two weeks after fertilization in healthy women trying to conceive and in women not seeking pregnancy.
-
Texting AI support for early pregnancy care in Philadelphia
This project will test whether a texting conversational AI (CIRCA) can recruit and support people in early pregnancy in the Philadelphia area.
-
Early lifestyle program for pregnant women with mildly high early-pregnancy blood sugar
This program tests whether starting diet, exercise, weight management and home blood‑glucose monitoring early in pregnancy helps women with mildly high early-pregnancy blood sugar have fewer large babies and preterm births.
-
Improving ultrasound image quality during early pregnancy using AI
This study is testing if using artificial intelligence can improve the quality of ultrasound images during early pregnancy to help doctors better identify important fetal features and reduce misdiagnoses.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.